Literature DB >> 7504587

Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.

M W Radomski1, P Vallance, G Whitley, N Foxwell, S Moncada.   

Abstract

OBJECTIVE: The aim was to study whether basal or cytokine stimulated generation of nitric oxide (NO) modulates platelet adhesion to human umbilical vein endothelial cells (HUVEC).
METHODS: The adhesion of 111In labelled human platelets to transfected HUVEC (SGHEC-7) was measured either alone or after incubation of SGHEC-7 cells for 18 h with interleukin-1 beta (IL-1 beta) and/or tumour necrosis factor alpha (TNF alpha). The activity of NO synthase in these cells was measured by formation of citrulline. The effects of dexamethasone (0.3 microM) and NG-monomethyl-L-arginine (L-NMMA, 100 microM) on these two variables were determined.
RESULTS: Stimulation of SGHEC-7 cells with IL-1 beta or TNF alpha (each at 1-30 ng.ml-1) caused them to express the inducible NO synthase, an effect that was prevented by dexamethasone. Platelet adhesion to unstimulated SGHEC-7 cells was < 0.1% (n = 3) and was increased to 0.7 (SEM 0.2)% by L-NMMA but was not affected by dexamethasone. Stimulation of the cells with IL-1 beta and TNF alpha increased platelet adhesion to a maximum of 2.2(0.4)%. This increase was enhanced by both dexamethasone and L-NMMA. The effect of L-NMMA was prevented by L-arginine.
CONCLUSIONS: Inhibition of NO synthesis by L-NMMA potentiates platelet adhesion to unstimulated SGHEC-7 cells, showing that basally released NO regulates platelet adhesion. Stimulation of SGHEC-7 cells by cytokines increases their adhesive properties but at the same time causes them to express the inducible NO synthase. Nitric oxide generated by this enzyme contributes to the modulation of the adhesive properties of the endothelial cells. Thus both constitutive and inducible NO synthases modulate endothelial cell thrombogenicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504587     DOI: 10.1093/cvr/27.7.1380

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  31 in total

1.  Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.

Authors:  D Maroeska Te Loo; Leo Monnens; Thea van der Velden; Mohammed Karmali; Lambertus van den Heuvel; Victor van Hinsbergh
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

2.  Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity.

Authors:  P Rosenkranz-Weiss; W C Sessa; S Milstien; S Kaufman; C A Watson; J S Pober
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  Inducible nitric oxide synthase in the cardiovascular system.

Authors:  K Bhagat; P Vallance
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

4.  Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.

Authors:  G A Limb; L Webster; H Soomro; S Janikoun; J Shilling
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

5.  Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide.

Authors:  J E Cartwright; D P Holden; G S Whitley
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

6.  Interferon-gamma regulates the interaction of RBL-2H3 cells with fibronectin through production of nitric oxide.

Authors:  F L Wills; M Gilchrist; A D Befus
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

7.  Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells.

Authors:  Károly Palatka; Zoltán Serfozo; Zoltán Veréb; Róbert Bátori; Beáta Lontay; Zoltán Hargitay; Zoltán Nemes; Miklós Udvardy; Ferenc Erdodi; István Altorjay
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 8.  Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.

Authors:  Terry C Major; Hitesh Handa; Gail M Annich; Robert H Bartlett
Journal:  J Biomater Appl       Date:  2014-06-16       Impact factor: 2.646

9.  cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.

Authors:  M A Moro; R J Russel; S Cellek; I Lizasoain; Y Su; V M Darley-Usmar; M W Radomski; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 10.  Targeted treatment in COPD: a multi-system approach for a multi-system disease.

Authors:  David Anderson; William Macnee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.